PNC Financial Services Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$196M Sell
6,971,622
-220,938
-3% -$5.88M 0.11% 133
2025
Q4
$179M Sell
7,192,560
-241,073
-3% -$6.08M 0.1% 140
2025
Q3
$189M Sell
7,433,633
-223,165
-3% -$5.51M 0.11% 138
2025
Q2
$186M Sell
7,656,798
-400,484
-5% -$9.34M 0.12% 128
2025
Q1
$204M Sell
8,057,282
-411,806
-5% -$10.8M 0.11% 111
2024
Q4
$225M Sell
8,469,088
-571,105
-6% -$15.5M 0.15% 102
2024
Q3
$262M Sell
9,040,193
-411,036
-4% -$12M 0.17% 97
2024
Q2
$264M Sell
9,451,229
-504,373
-5% -$13.9M 0.18% 88
2024
Q1
$276M Sell
9,955,602
-791,684
-7% -$22M 0.19% 86
2023
Q4
$309M Sell
10,747,286
-835,315
-7% -$25.3M 0.24% 76
2023
Q3
$384M Sell
11,582,601
-379,869
-3% -$13.4M 0.33% 56
2023
Q2
$439M Sell
11,962,470
-271,951
-2% -$10.6M 0.37% 55
2023
Q1
$499M Sell
12,234,421
-117,186
-0.9% -$5.06M 0.44% 45
2022
Q4
$633M Sell
12,351,607
-37,945
-0.3% -$1.82M 0.61% 31
2022
Q3
$542M Sell
12,389,552
-309,714
-2% -$15M 0.57% 36
2022
Q2
$666M Sell
12,699,266
-51,607
-0.4% -$2.63M 0.65% 29
2022
Q1
$660M Sell
12,750,873
-223,512
-2% -$11.6M 0.58% 36
2021
Q4
$766M Buy
12,974,385
+91,171
+0.7% +$4.52M 0.63% 28
2021
Q3
$554M Sell
12,883,214
-448,463
-3% -$19.9M 0.51% 39
2021
Q2
$522M Sell
13,331,677
-418,904
-3% -$16.3M 0.47% 45
2021
Q1
$498M Sell
13,750,581
-908,724
-6% -$32.3M 0.48% 46
2020
Q4
$540M Sell
14,659,305
-1,882,700
-11% -$69.1M 0.54% 35
2020
Q3
$576M Buy
16,542,005
+30,540
+0.2% +$1.07M 0.71% 26
2020
Q2
$512M Sell
16,511,465
-644,057
-4% -$21.9M 0.68% 31
2020
Q1
$531M Sell
17,155,522
-317,910
-2% -$10.8M 0.67% 23
2019
Q4
$650M Sell
17,473,432
-1,558,404
-8% -$55.5M 0.64% 24
2019
Q3
$649M Sell
19,031,836
-1,090,917
-5% -$39.7M 0.65% 20
2019
Q2
$827M Sell
20,122,753
-375,334
-2% -$14.9M 0.81% 15
2019
Q1
$826M Sell
20,498,087
-447,389
-2% -$17.9M 0.83% 15
2018
Q4
$867M Sell
20,945,476
-442,140
-2% -$18.4M 0.97% 13
2018
Q3
$894M Sell
21,387,616
-90,929
-0.4% -$3.5M 0.85% 13
2018
Q2
$739M Sell
21,478,545
-389,865
-2% -$13.3M 0.73% 14
2018
Q1
$736M Sell
21,868,410
-232,480
-1% -$7.99M 0.73% 15
2017
Q4
$759M Buy
22,100,890
+2,327,701
+12% +$79.4M 0.74% 15
2017
Q3
$670M Sell
19,773,189
-623,852
-3% -$20.1M 0.7% 18
2017
Q2
$650M Sell
20,397,041
-270,723
-1% -$8.54M 0.7% 18
2017
Q1
$671M Sell
20,667,764
-3,515,766
-15% -$111M 0.74% 17
2016
Q4
$745M Sell
24,183,530
-853,659
-3% -$26.1M 0.85% 15
2016
Q3
$805M Buy
25,037,189
+11,465
+0% +$383K 0.94% 13
2016
Q2
$836M Sell
25,025,724
-587,740
-2% -$18.8M 0.98% 10
2016
Q1
$720M Sell
25,613,464
-81,865
-0.3% -$2.34M 0.84% 14
2015
Q4
$787M Buy
25,695,329
+3,713,108
+17% +$117M 0.93% 13
2015
Q3
$655M Sell
21,982,221
-451,989
-2% -$14.5M 0.78% 17
2015
Q2
$714M Sell
22,434,210
-542,666
-2% -$17.7M 0.8% 14
2015
Q1
$758M Sell
22,976,876
-454,557
-2% -$14.5M 0.83% 13
2014
Q4
$692M Sell
23,431,433
-236,163
-1% -$6.77M 0.76% 18
2014
Q3
$664M Buy
23,667,596
+3,137,292
+15% +$88.1M 0.78% 19
2014
Q2
$578M Sell
20,530,304
-328,492
-2% -$9.36M 0.74% 17
2014
Q1
$636M Sell
20,858,796
-284,771
-1% -$8.49M 0.84% 14
2013
Q4
$614M Sell
21,143,567
-540,964
-2% -$15.7M 0.82% 13
2013
Q3
$591M Sell
21,684,531
-3,119,576
-13% -$84.9M 0.86% 13
2013
Q2
$659M Buy
+24,804,107
New +$685M 0.96% 12

Other funds holding PFE

PNC Financial Services Group's PFE Position: Q1 2026 in Review

PNC Financial Services Group reduced its Pfizer (PFE) stake by 3.1% in Q1 2026, selling an estimated $5.88M and leaving 6,971,622 shares worth $196M. The position accounts for 0.11% of the portfolio, ranked #133.

PNC Financial Services Group first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $894M in Q3 2018. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • PNC Financial Services Group held 6,971,622 shares of Pfizer worth $196M as of Q1 2026.
  • PNC Financial Services Group sold 220,938 Pfizer shares in Q1 2026, an estimated $5.88M.
  • Pfizer made up 0.11% of PNC Financial Services Group's portfolio in Q1 2026, its #133 holding.
  • PNC Financial Services Group first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • PNC Financial Services Group's Pfizer position peaked at $894M in Q3 2018.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.